ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

GLUE Monte Rosa Therapeutics Inc

3.83
-0.18 (-4.49%)
2024年6月15日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Monte Rosa Therapeutics Inc GLUE NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.18 -4.49% 3.83 05:30:00
始値 安値 高値 終値 前日終値
3.99 3.71 4.11 3.83 4.01
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/1421:45GLOBEMonte Rosa Therapeutics Presents Preclinical Data at EULAR..
2024/6/1405:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1305:00EDGAR2Form 8-K - Current report
2024/6/0605:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0605:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0605:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0605:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0605:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/6/0605:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/5/3020:18EDGAR2Form 8-K - Current report
2024/5/3020:00GLOBEMonte Rosa Therapeutics Announces Leadership Team Promotions
2024/5/2120:00GLOBEMonte Rosa Therapeutics Presents Preclinical Data at..
2024/5/1705:06EDGAR2Form 8-K - Current report
2024/5/1705:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/5/1620:00GLOBEMonte Rosa Therapeutics Announces Pricing of $100 Million..
2024/5/1605:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/5/1605:01GLOBEMonte Rosa Therapeutics Announces Proposed Public Offering..
2024/5/0920:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0920:05EDGAR2Form 8-K - Current report
2024/5/0920:00GLOBEMonte Rosa Therapeutics Announces First Quarter 2024..
2024/5/0305:01GLOBEMonte Rosa Therapeutics Announces the Departure of Owen..
2024/3/1420:00GLOBEMonte Rosa Therapeutics Announces Fourth Quarter and Full..
2024/3/1120:00GLOBEMonte Rosa Therapeutics Announces Initiation of IND Enabling..
2024/1/3121:00GLOBEMonte Rosa Therapeutics to Participate in Upcoming Investor..
2024/1/0821:47EDGAR2Form 8-K - Current report
2024/1/0821:15GLOBEMonte Rosa Therapeutics Provides Corporate Update and Key..
2024/1/0506:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0321:00GLOBEMonte Rosa Therapeutics to Present at the 42nd Annual J.P...
2023/11/2121:00GLOBEMonte Rosa Therapeutics to Present at Piper Sandler..
2023/11/0921:27EDGAR2Form 8-K - Current report
2023/11/0921:00GLOBEMonte Rosa Therapeutics Announces Third Quarter 2023..
2023/11/0800:00GLOBEMonte Rosa Therapeutics Presents Preclinical Data at ACR..
2023/10/2720:00GLOBEMonte Rosa Therapeutics to Participate in Upcoming Investor..
2023/10/2706:01EDGAR2Form 8-K - Current report
2023/10/2705:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/2705:30GLOBEMonte Rosa Therapeutics Announces $25 Million Registered..
2023/10/1720:55EDGAR2Form 8-K - Current report
2023/10/1720:00GLOBEMonte Rosa Therapeutics Announces Interim PK/PD and Clinical..
2023/8/1905:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/8/1606:16EDGAR2Form 144 - Report of proposed sale of securities
2023/8/1020:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1020:19EDGAR2Form 8-K - Current report
2023/8/1020:15GLOBEMonte Rosa Therapeutics Announces Second Quarter 2023..
2023/7/2620:53EDGAR2Form 8-K - Current report
2023/7/2620:30GLOBEMonte Rosa Therapeutics Appoints Dr. Anthony M. Manning to..

最近閲覧した銘柄

Delayed Upgrade Clock